GSK KK Of Japan To Reveal Ties To Doctors In Trials, Research
This article was originally published in PharmAsia News
Executive Summary
The Japanese subsidiary of U.K.-based GlaxoSmithKline says it will disclose payments it has made to physicians and institutions involved in research or testing of its products